JP Morgan Chase
SQZ

JP Morgan Chase’s SQZ Biotechnologies Company SQZ Stock Holding History

JP Morgan Chase’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,075
Closed -$5K – 7211
2022
Q3 		$5K Sell
2,075
-128,172
-98% -$385K ﹤0.01% 6115
2022
Q2 		$414K Buy
130,247
+13,016
+11% +$46.8K ﹤0.01% 4679
2022
Q1 		$564K Sell
117,231
-8,882
-7% -$56.4K ﹤0.01% 4632
2021
Q4 		$1.13M Sell
126,113
-110,896
-47% -$1.36M ﹤0.01% 4299
2021
Q3 		$3.42M Buy
237,009
+54,980
+30% +$745K ﹤0.01% 3345
2021
Q2 		$2.63M Buy
182,029
+166,879
+1,102% +$2.18M ﹤0.01% 3593
2021
Q1 		$207K Buy
15,150
+2,992
+25% +$60.8K ﹤0.01% 5134
2020
Q4 		$352K Buy
+12,158
New +$310K ﹤0.01% 4565

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

JP Morgan Chase's SQZ Position: Q4 2022 in Review

JP Morgan Chase sold out of SQZ Biotechnologies Company (SQZ) in Q4 2022, closing a stake of 2,075 shares — an estimated $5K sold.

JP Morgan Chase first reported a position in SQZ in Q4 2020 and held it in 8 quarters. The position peaked at $3.42M in Q3 2021. 36 funds tracked by Wall St. Rank hold SQZ as of Q4 2022.

  • JP Morgan Chase reported no remaining SQZ Biotechnologies Company position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 2,075 SQZ Biotechnologies Company shares in Q4 2022, an estimated $5K.
  • JP Morgan Chase first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 8 quarters.
  • JP Morgan Chase's SQZ Biotechnologies Company position peaked at $3.42M in Q3 2021.
  • 36 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.